I will note the icloud mail web interface is utter garbage.

Thankfully I've been becoming less reliant on my gmail inbox. But also, it appears my various efforts for blocking malicious content may be blocking these ads because I don't see them on my home network.

So I'd argue there's no established link, but there might be an obvious correlation that might warrant more study.

It's a shame, really, because it seems like the expensive bulbs might meet your needs while their cheaper ones don't. Granted, the filament bulbs do seem to fall more in line with the regular bulbs, so might be worth exploring.

My local Home Depot used to take batteries, but only non-lithium ion batteries. And sometime last year they stopped accepting any batteries.

I still haven't found a local place that I can easily access to get rid of these things. And I'm tired of keeping them around.

It especially doesn't help that electronics, including with non-replaceable batteries, including those that get angry when abused, are being designed to be disposable to begin with.

And yeah, I know there's a high level of apathy about the problem with the masses. Even though the information can be, for the most part, found, people just don't care enough.

I've taken various GLP-1 RA over a decade for glycemic management (I'm on Mounjaro now). They still work great for this. But I have to do the work to maintain my body, now.

Mounjaro is a trade name for a diabetes drug and that won't change. So no, it is not soundly rejected.

It's not as simple as "SQUIRT JUICE INSIDE ME GET THINNER AND CURE DIABETES". There's a lot more to this than you seem to understand.

GLP-1 RA does NOT achieve a reduced A1c through weight loss. It achieves improved glycemic control by slowing the release of glucose into the blood as well as promoting increased production of insulin in response to glucose. The overall result is a reduction in blood glucose.

A1c is a measure of your glycemic health that spans around 90 days with heavier weight on more recent trends. It's like a longer blood glucose average measurement. There are actually algorithms that can calculate an estimate of your A1c based on blood glucose trends, which is referred to GMI (glucose management indicator).

The gastric effects leading to feeling full sooner and longer are a side effect and is what leads to weight loss. It also fades with time. Having been on various GLP-1 RAs over a decade, they don't provide this benefit to me anymore. Even with Mounjaro also being a GIP, it's just doing its primary job for me.

This is not a new hotness. And many diabetics have used this drug class for a long time.

And yeah, you're jumping into conspiracy theory. Ramping up production would likely take significant investment. Do they have the resources? Probably. But given the weight loss benefit is temporary (seriously, it is, ask anyone who has used one of these drugs for a significant amount of time), do you think they're going to sink significant investment into production when demand is going to wane in a few years? Well, you see, their investors are going to say no, and they hold the final say.

And yeah, the weight loss benefit is a temporary benefit. It may last a few years, but it fades. This is not a new drug class. The weight loss aspect to it is also not new (Saxenda, the weight loss variant of Victoza, released in 2014). Liraglutide was in trials for weight management when I started Victoza. That was a decade ago. I'm on Mounjaro now for glycemic management and it works great for that. But it's not doing anything for appetite, delayed gastric emptying, etc.

Yeah, these drugs aren't new but the wide world is just learning about the weight loss aspect. So they don't know this is a temporary solution.